224 related articles for article (PubMed ID: 1797561)
1. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264.
Durieux C; Ruiz-Gayo M; Roques BP
Eur J Pharmacol; 1991 Dec; 209(3):185-93. PubMed ID: 1797561
[TBL] [Abstract][Full Text] [Related]
2. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
[TBL] [Abstract][Full Text] [Related]
4. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
[TBL] [Abstract][Full Text] [Related]
5. Characterization of SNF 9007, a novel cholecystokinin/opoid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transport.
Rao RK; Levenson S; Fang SN; Hruby VJ; Yamamura HI; Porreca F
J Pharmacol Exp Ther; 1994 Feb; 268(2):1003-9. PubMed ID: 8113956
[TBL] [Abstract][Full Text] [Related]
6. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
7. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
[TBL] [Abstract][Full Text] [Related]
8. The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice.
Hernando F; Fuentes JA; Roques BP; Ruiz-Gayo M
Eur J Pharmacol; 1994 Aug; 261(3):257-63. PubMed ID: 7813546
[TBL] [Abstract][Full Text] [Related]
9. The selective CCK-B agonist, BC 264 injected in the antero-lateral part of the nucleus accumbens, reduces the spontaneous alternation behaviour of rats.
Daugé V; Derrien M; Blanchard JC; Roques BP
Neuropharmacology; 1992 Jan; 31(1):67-75. PubMed ID: 1542405
[TBL] [Abstract][Full Text] [Related]
10. CCK-8-related C-terminal tetrapeptides: affinities for central CCKB and peripheral CCKA receptors.
Harhammer R; Schäfer U; Henklein P; Ott T; Repke H
Eur J Pharmacol; 1991 Dec; 209(3):263-6. PubMed ID: 1797567
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Noble F; Smadja C; Roques BP
J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
[TBL] [Abstract][Full Text] [Related]
12. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.
Dauge V; Bohme GA; Crawley JN; Durieux C; Stutzmann JM; Feger J; Blanchard JC; Roques BP
Synapse; 1990; 6(1):73-80. PubMed ID: 2399491
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
14. CCK-B antagonists exhibit antidepressant-like effects and potentiate endogenous enkephalin analgesia. Correlation with in vivo binding affinities and brain penetration.
Durieux C; Derrien M; Maldonado R; Valverde O; Blommaert A; Fournié-Zaluski MC; Roques BP
Ann N Y Acad Sci; 1994 Mar; 713():355-7. PubMed ID: 8185186
[No Abstract] [Full Text] [Related]
15. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
16. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
[TBL] [Abstract][Full Text] [Related]
17. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
Staley J; Jensen RT; Moody TW
Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
[TBL] [Abstract][Full Text] [Related]
18. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
20. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
Maldonado R; Valverde O; Derrien M; Tejedor-Real P; Roques BP
Pharmacol Biochem Behav; 1994 Jun; 48(2):363-9. PubMed ID: 8090802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
